US 7776879
Quinuclidine carbamate derivatives and their use as M3 antagonists
granted A61PA61P1/00A61P1/04
Quick answer
US patent 7776879 (Quinuclidine carbamate derivatives and their use as M3 antagonists) held by Almirall, S.A. expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Almirall, S.A.
- Grant date
- Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61P, A61P1/00, A61P1/04, A61P1/06, A61P11/00